Participate in Share Chat. Set up virtual watchlists and portfolios See more trades and share info.
Register for FREE Now
Final results from Immunodiagnostic Systems (IDS) were broadly in line with expectations, as the company outlined a new five-year strategy to double r...
Create a free LSE account to:
Already have an account? Sign In
Don't have an account? Register for FREE